摘要
目的探讨肝癌介入治疗患者实施临床路径管理的临床护理效果。方法选取山东大学第四人民医院2007年5月-2010年4月实施临床路径管理前进行肝癌介入治疗的181例患者为对照组,2012年5月-2014年4月实施临床路径管理后进行肝癌介入治疗的194例患者为观察组,比较两组患者在生存质量、住院时间、治疗费用、不良反应发生率以及护理满意度等方面的差异。结果两组患者在身体功能、心理状况、社会功能三个维度比较,差异有高度统计学意义（P〈0.01）,而在物质生活维度比较,差异无统计学意义（P〉0.05）。观察组不良反应失眠（12.9%）、恶心呕吐（12.9%）、肝区疼痛（10.3%）、尿潴留（5.2%）、穿刺点出血（0.0%）发生率均低于对照组（50.3%、44.8%、38.7%、17.7%、11.6%）,差异有统计学意义（P〈0.05）。观察组患者住院时间[（9.4±1.8）d]少于对照组[（13.2±2.4）d],差异有统计学意义（P〈0.05）;,观察组治疗费用[（20 472.8±389.1）元]虽低于对照组[（21 535.6±442.7）元],但差异无统计学意义（P〉0.05）。两组患者满意度比较,差异有统计学意义（P〈0.05）。结论临床路径管理有助于提高肝癌介入治疗患者生存质量及护理满意度,减少不良反应发生率,并缩短患者住院时间及减少住院费用,具有一定临床应用价值。
Objective To evaluate the clinical nursing effect of clinical pathway management in patients with interventional therapy. Methods In the Fourth People＇s Hospital of Ji＇nan City, from May 2007 to April 2010, before implementing the clinical path management, 181 hepatocellular carcinoma patients with interventional therapy were selected as control group; from May 2012 to April 2014, after implementing the clinical pathway management, 194 hepatocellular carcinoma patients with interventional therapy were selected as observation group. The differences of survive treatment, hospital stay, treatment cost, incidence of adverse reactions and nursing satisfaction of patients between two groups were compared. Results The three dimensions of physical function, mental status, social function in two groups were compared, the differences were statistically significant（P〈0.01）, but the physical dimensions of life were compared, the difference was not statistically significant（P〈0.05）. The incidence of adverse reactions, insomnia（12.9%）,nausea and vomiting（12.9%）, liver pain（10.3%）, urinary retention（5.2%） of observation group were lower than those of control group（50.3%, 44.8%, 38.7%, 17.7%, 11.6%）, the differences were statistically significant（P〈0.05）. The hospital stays of observation group [（9.4±1.8） d] was less than that of control group [（13.2±2.4） d], the difference was statistically significant（P〈0.05）; the treatment cost of observation group [（20 472.8±389.1） yuan] was less than that of control group [（21 535.6±442.7） yuan], but the difference was not statistically significant（P〉0.05）. The satisfaction of patients in two groups was compared, the difference was statistically significant（P〈0.05）. Conclusion Clinical pathway management interventional therapy helps improve the quality of life and patient satisfaction with care, reduce the incidence of adverse reactions, and shorten hospital stay of patients and reduce hospital costs, it has some clinical value.
出处
《中国医药导报》
CAS
2015年第28期160-163,共4页
China Medical Herald
关键词
临床路径疗程
肝癌
介入治疗
护理
Clincal pathway maanagent
Liver
Interventional therapy
Nursing
